相关实验视频
Updated: Jul 8, 2025

Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing
Published on: May 8, 2021
减少需要重复尿液药物测试的需要,由测量不确定性决定的灰色区域
Kagan Huysal1, Yasemin Üstündağ1, Hatice Azra Çağlak1
1University of Health Sciences, Bursa Yüksek Ihtisas Training and Research Hospital, Department of Clinical Biochemistry, Bursa, Turkey.
测量不确定性 (MU) 可以识别尿液药物查中的"灰色区域",可能减少对胺和大麻素等物质的不必要重复测试.
科学领域:
- 临床化学 临床化学
- 法医毒理学 法医毒理学
- 实验室医学 实验室医学
背景情况:
- 尿液药物查依赖于立法值来报告积极的结果.
- 样品的重复测试是一种标准的实验室实践,以确保准确性.
- 减少重复测试可以提高实验室的效率和周转时间.
研究的目的:
- 调查测量不确定性 (MU) 在确定尿液药物查的"灰色区域"中的有用性.
- 为了确定MU是否可以最大限度地减少确认重复测试的需要.
- 提高临床实验室中非法物质检测的效率.
主要方法:
- 对2020年1月至2022年7月期间测试的尿样进行回顾性分析.
- 对安非他胺,大麻素,可卡因和阿片类药物参数的MU计算.
- 将"灰色区域"定义为 ± MU 的切割值.
主要成果:
- 测量不确定性 (MU) 为测试结果提供了可量化的范围.
- "灰色区域" (切线±MU) 可以表示需要进一步调查的样本.
- 这种方法有可能简化尿液查测试的报告.
结论:
- 测量不确定性是定义尿液药物查灰色区域的一个有价值的工具.
- 使用MU可以帮助实验室减少重复测试的频率.
- 这种方法提供了一种更有效的方法来管理毒理学边界阳性结果.
更多相关视频
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
07:45Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis
Published on: February 9, 2021
相关概念视频
Determination of Renal Drug Clearance: Graphical and Midpoint Methods
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
One-Compartment Open Model: Urinary Excretion Data and Determination of k
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Data Validation
Key parameters for method validation include:
Uncertainty in Measurement: Accuracy and Precision